about
Treatment of ischaemic stroke with prostacyclin.Clinical utility of adjunctive retigabine in partial onset seizures in adults.Mechanisms of action of antiepileptic drugs.Novel approaches to anticonvulsant drug discovery.The problem of osteoporosis in epileptic patients taking antiepileptic drugs.Antiepileptic drugs and adverse skin reactions: An update.Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.Epilepsy coexisting with depression.The prophylactic use of antiepileptic drugs in patients scheduled for neurosurgery.Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.A viewpoint on rational and irrational fixed-drug combinations
P50
Q34708559-2970EF01-5B62-4AE1-8544-AFAD24639C86Q35717049-B38D27AA-EC39-4343-A10B-C6FEA7D19AEDQ36002922-840D89C1-1AB5-4B5F-B4D9-741488D88254Q38139499-D7353C5A-D001-4979-9871-C2139E71545EQ38211406-BF86E024-AC62-4D4E-86C8-E4E22BE42D0FQ38453964-C40AD342-AF97-493E-A875-9A7F9F60AA03Q38856602-138F16E3-59BC-4714-B19F-1F33A324B495Q38955919-087B2AD1-389E-464F-A3A7-229B02D8FA45Q42699484-2B53A4A5-6845-4E1E-9098-E6BE86C66B1EQ51771465-BA44E015-04E3-4017-912E-33AA37EB4927Q90338006-18C19ADC-EF1D-4A5D-BD0D-BAEEB53E279B
P50
description
Pools onderzoekster
@nl
researcher
@en
name
B Blaszczyk
@ast
B Blaszczyk
@es
Barbara Błaszczyk
@ca
Barbara Błaszczyk
@cs
Barbara Błaszczyk
@en
Barbara Błaszczyk
@gl
Barbara Błaszczyk
@hr
Barbara Błaszczyk
@hsb
Barbara Błaszczyk
@it
Barbara Błaszczyk
@nl
type
label
B Blaszczyk
@ast
B Blaszczyk
@es
Barbara Błaszczyk
@ca
Barbara Błaszczyk
@cs
Barbara Błaszczyk
@en
Barbara Błaszczyk
@gl
Barbara Błaszczyk
@hr
Barbara Błaszczyk
@hsb
Barbara Błaszczyk
@it
Barbara Błaszczyk
@nl
prefLabel
B Blaszczyk
@ast
B Blaszczyk
@es
Barbara Błaszczyk
@ca
Barbara Błaszczyk
@cs
Barbara Błaszczyk
@en
Barbara Błaszczyk
@gl
Barbara Błaszczyk
@hr
Barbara Błaszczyk
@hsb
Barbara Błaszczyk
@it
Barbara Błaszczyk
@nl
P106
P1412
P1559
Barbara Błaszczyk
@pl
P21
P27
P31
P496
0000-0003-0253-2345